These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27466852)

  • 1. Immunomodulators in the Treatment of Nasal Polyposis.
    Halderman AA; Lane AP
    Adv Otorhinolaryngol; 2016; 79():103-13. PubMed ID: 27466852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Therapeutics for Rhinosinusitis with Nasal Polyposis.
    Thomas AJ; Alt JA
    Adv Otorhinolaryngol; 2016; 79():138-47. PubMed ID: 27466856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence and role of autoantibodies in chronic rhinosinusitis with nasal polyps.
    Macri GF; Greco A; Marinelli C; Gallo A; Fusconi M; De Virgilio A; De Vincentiis M
    Int J Immunopathol Pharmacol; 2014; 27(2):155-61. PubMed ID: 25004827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy.
    Kariyawasam HH; James LK
    Drug Des Devel Ther; 2020; 14():5483-5494. PubMed ID: 33328726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the problem of medicamentous therapy of chronic polypous rhinosinusitis].
    Volkov AG; Trofimenko SL; Riabtseva OA; Bodzhokov AR
    Vestn Otorinolaringol; 2010; (4):41-4. PubMed ID: 21105345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Aldinger JP; Dobyns T; Lam K; Han JK
    Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps.
    Miyake MM; Nocera A; Levesque P; Guo R; Finn CA; Goldfarb J; Gray S; Holbrook E; Busaba N; Dolci JEL; Bleier BS
    J Allergy Clin Immunol; 2017 Jul; 140(1):271-273. PubMed ID: 28126245
    [No Abstract]   [Full Text] [Related]  

  • 10. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary human sinonasal epithelial cell culture model for topical drug delivery in patients with chronic rhinosinusitis with nasal polyposis.
    Bleier BS; Mulligan RM; Schlosser RJ
    J Pharm Pharmacol; 2012 Mar; 64(3):449-56. PubMed ID: 22309277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP).
    Scadding GK; Scadding GW
    J Allergy Clin Immunol; 2022 Mar; 149(3):895-897. PubMed ID: 34752829
    [No Abstract]   [Full Text] [Related]  

  • 14. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps.
    Milara J; Morell A; Ballester B; Armengot M; Morcillo E; Cortijo J
    J Allergy Clin Immunol; 2017 Mar; 139(3):855-862.e13. PubMed ID: 27639937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant protein A and D in chronic rhinosinusitis with nasal polyposis and corticosteroid response.
    Salman S; Akpinar ME; Yigit O; Gormus U
    Am J Rhinol Allergy; 2012; 26(2):e76-80. PubMed ID: 22487281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment.
    Chin D; Harvey RJ
    Curr Opin Otolaryngol Head Neck Surg; 2013 Feb; 21(1):23-30. PubMed ID: 23172039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
    Brown WC; Senior B
    Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms underlying glucocorticoid resistance in chronic rhinosinusitis with nasal polyps].
    Zhang YY; Lou HF; Wang CS; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):154-160. PubMed ID: 29429191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of biologics in chronic sinusitis with nasal polyps.
    Wang C; Zhang L
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.